Rationale and design of the HIT-CF organoid study: stratifying cystic fibrosis patients based on intestinal organoid response to different CFTR-modulators

Rationale and design of the HIT-CF organoid study: stratifying cystic fibrosis patients based on intestinal organoid response to different CFTR-modulators https://t.co/2irt7eWnQa https://t.co/7ncnaOhWKV

RT @MedicalEvidence: The HIT-CF Organoid Study applies the intestinal organoid model for personalized medicine in patients with rare varian…

The HIT-CF Organoid Study applies the intestinal organoid model for personalized medicine in patients with rare variant cystic fibrosis and aims to create a new pathway for access to CFTR-modulating drugs for patients with ultra-rare CFTR variants. https